title: The changing roles of industry and academia.
abstract: Over the past 25 years both the quality and quantity of pharmaceutical and biopharmaceutical research has changed. Formerly rigidly separated research efforts in academic institutions and the biopharmaceutical industry have become increasingly transparent to one another. Industry has in some cases scaled down its internal research efforts, while enhancing its outreach to basic research in academic institutions. In parallel, research at academic institutions has-in some cases-added a focus on application of discoveries to patient needs. This porosity between industry and academia has created opportunities for more rapid translation of basic discoveries to patient needs. Additionally, both physicians and fundamental scientists have broadened their career opportunities, and movement between industry and academia-almost unheard of two decades ago-now occurs regularly. At the same time, numerous examples exist of how these translational efforts have benefited not only patients but also investigators and academic institutions as well. Despite many potential advantages of closer interactions between industry and academia, other issues, such as conflicts of interest (both real and perceived), continue to pose challenges.
authors.affiliation: Dermira, Redwood City, California 94061, USA. eugene.bauer@stanford.edu
authors.forename: Eugene A
authors.initials: EA
authors.lastname: Bauer
authors.forename: David E
authors.initials: DE
authors.lastname: Cohen
mesh_terms: D000046:Academic Medical Centers / Q000941:ethics / Q000639:trends*; D000047:Academies and Institutes / Q000941:ethics / Q000639:trends*; D035843:Biomedical Research / Q000941:ethics / Q000639:trends*; D016265:Conflict of Interest; D004345:Drug Industry / Q000941:ethics / Q000639:trends*; D006801:Humans